Home/Filings/4/0001493152-23-032321
4//SEC Filing

Frelick Jeff 4

Accession 0001493152-23-032321

CIK 0001419554other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 11:34 AM ET

Size

5.2 KB

Accession

0001493152-23-032321

Insider Transaction Report

Form 4
Period: 2023-09-11
Frelick Jeff
Chief Executive Officer
Transactions
  • Purchase

    Common Stock

    2023-09-11$0.69/sh+9,500$6,53017,204 total
Footnotes (1)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6799 to $0.6898, inclusive. Mr. Frelick undertakes to provide Bone Biologics Corporation, any security holder of Bone Biologics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

Bone Biologics Corp

CIK 0001419554

Entity typeother

Related Parties

1
  • filerCIK 0001645093

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 11:34 AM ET
Size
5.2 KB